BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37758434)

  • 1. Validation of Risk Stratification for Cardiac Events in Pregnant Women With Valvular Heart Disease.
    Pande SN; Yavana Suriya J; Ganapathy S; Pillai AA; Satheesh S; Mondal N; Harichandra Kumar KT; Silversides C; Siu SC; D'Souza R; Keepanasseril A
    J Am Coll Cardiol; 2023 Oct; 82(14):1395-1406. PubMed ID: 37758434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of risk prediction scores in pregnant women with congenital heart disease.
    Kim YY; Goldberg LA; Awh K; Bhamare T; Drajpuch D; Hirshberg A; Partington SL; Rogers R; Ruckdeschel E; Tobin L; Venuti M; Levine LD
    Congenit Heart Dis; 2019 May; 14(3):470-478. PubMed ID: 30729681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease.
    Baghel J; Keepanasseril A; Pillai AA; Mondal N; Jeganathan Y; Kundra P
    Heart; 2020 Sep; 106(18):1400-1406. PubMed ID: 32601124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac complications during pregnancy are better predicted with the modified WHO risk score.
    Pijuan-Domènech A; Galian L; Goya M; Casellas M; Merced C; Ferreira-Gonzalez I; Marsal-Mora JR; Dos-Subirà L; Subirana-Domènech MT; Pedrosa V; Baró-Marine F; Manrique S; Casaldàliga-Ferrer J; Tornos P; Cabero L; Garcia-Dorado D
    Int J Cardiol; 2015 Sep; 195():149-54. PubMed ID: 26043149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for complications in pregnant women with heart disease, a retrospective study.
    Chumpathong S; Sirithaweesit C; Pechpaisit N; Suraseranivongse S; von Bormann B; Titapant V; Parakkamodom S
    J Med Assoc Thai; 2014 Jul; 97(7):730-5. PubMed ID: 25265772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and cardiac maternal outcomes in women with inherited cardiomyopathy: interest of the CARPREG II risk score.
    Wallet T; Legrand L; Isnard R; Gandjbakhch E; Pousset F; Proukhnitzky J; Dommergues M; Nizard J; Charron P
    ESC Heart Fail; 2024 Jun; 11(3):1506-1514. PubMed ID: 38361389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of risk stratification models for pregnancy in congenital heart disease.
    Denayer N; Troost E; Santens B; De Meester P; Roggen L; Moons P; Van Calsteren K; Budts W; Van De Bruaene A
    Int J Cardiol; 2021 Jan; 323():54-60. PubMed ID: 32931856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?
    Bredy C; Deville F; Huguet H; Picot MC; De La Villeon G; Abassi H; Avesani M; Begue L; Burlet G; Boulot P; Fuchs F; Amedro P
    Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):177-183. PubMed ID: 35472215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease.
    Balci A; Sollie-Szarynska KM; van der Bijl AG; Ruys TP; Mulder BJ; Roos-Hesselink JW; van Dijk AP; Wajon EM; Vliegen HW; Drenthen W; Hillege HL; Aarnoudse JG; van Veldhuisen DJ; Pieper PG;
    Heart; 2014 Sep; 100(17):1373-81. PubMed ID: 25034822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of risk models predicting cardiac complications in pregnant women with congenital heart disease: a meta-analysis.
    Wang TKM; Lowe B; Hlohovsky S; O'Donnell C
    Intern Med J; 2020 Apr; 50(4):481-484. PubMed ID: 32270622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive accuracy of three clinical risk assessment systems for cardiac complications among Chinese pregnant women with congenital heart disease.
    Fu Q; Lin J
    Int J Gynaecol Obstet; 2016 Aug; 134(2):140-4. PubMed ID: 27177511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Prediction of Cardiovascular Complications in Pregnant Women With Heart Disease.
    Martins LC; Freire CM; Capuruçu CA; Nunes Mdo C; Rezende CA
    Arq Bras Cardiol; 2016 Apr; 106(4):289-96. PubMed ID: 26959402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
    Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
    ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study.
    Silversides CK; Grewal J; Mason J; Sermer M; Kiess M; Rychel V; Wald RM; Colman JM; Siu SC
    J Am Coll Cardiol; 2018 May; 71(21):2419-2430. PubMed ID: 29793631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center.
    Jastrow N; Meyer P; Khairy P; Mercier LA; Dore A; Marcotte F; Leduc L
    Int J Cardiol; 2011 Sep; 151(2):209-13. PubMed ID: 20659773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac risk prediction model for pregnant women with structural heart disease in Eastern China.
    Fu Q; Wang XJ; Wang BS; Lin JH
    Int J Gynaecol Obstet; 2019 Jun; 145(3):324-330. PubMed ID: 30932184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Complications during Pregnancy Related to Parity in Women with Congenital Heart Disease.
    Furenäs E; Eriksson P; Wennerholm UB; Dellborg M
    Cardiology; 2020; 145(8):533-542. PubMed ID: 32659772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 3 Risk Estimation Methods for Predicting Cardiac Outcomes in Pregnant Women With Congenital Heart Disease.
    Lu CW; Shih JC; Chen SY; Chiu HH; Wang JK; Chen CA; Chiu SN; Lin MT; Lee CN; Wu MH
    Circ J; 2015; 79(7):1609-17. PubMed ID: 25959432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.